Daniel Zelterman

3PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 16, 2023
AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers.

Maysa M Abu-Khalaf, K Alex Hodge, Christos Hatzis

|Sep 12, 2019
A two-stage phase II clinical trial design with nested criteria for early stopping and efficacy.

Michelle DeVeaux, Michael Kane, Wei Wei

|Aug 12, 2018
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers.

S N Gettinger, J Choi, N Mani

Pageof 1

Frequent Collaborators

1 joint publications

Mariaelena Pierobon